Ionic liquids and production and use thereof
AssigneeCelanese Chemicals Europe GmbH
InventorsHelmut Bahrmann, Hans Bohnen
Life of this patent
Estimating the term…
Abstract
The use of (A) a polypeptide comprising the amino acid sequence of SEQ ID NO:2, or a functionally equivalent variant of that amino acid sequence, or (B) a polynucleotide comprising a nucleotide sequence encoding the polypeptide (A), or (C) an antibody which is immunoreactive with the polypeptide (A), or (D) an antisense oligonucleotide comprising a nucleotide sequence complementary to that of polynucleotide (B), or (E) a polynucleotide probe comprising at least 15 consecutive nucleotides of (B), in the preparation of a pharmaceutical for the diagnosis or treatment of a neutrophil-associated inflammatory disease.
Claims33
A nonaqueous ionic liquid of the formula (Q+)aAa−, where Q+ is a singly charged ammonium cation which may be substituted by organic radicals or the equivalent of a multiply charged ammonium cation which may be substituted by organic radicals, Aa− is the anion of a sulfonated or carboxylated triester of phosphorous acid and a is an integer equal to or greater than 1.
Dependencies are inferred from the claim text.